Xolair, a medication originally developed to treat asthma, has now been approved to prevent severe allergic reactions to food. This medication is designed to target and block the body’s immune response to specific food allergens, reducing the risk of anaphylaxis. This approval provides hope for individuals with serious food allergies, such as peanuts and tree nuts, who are at risk of life-threatening reactions. By expanding the use of Xolair to food allergies, it addresses a critical need for effective treatment options for those at risk of severe allergic reactions.
Source link
FDA Approves First Drug To Treat Food Allergies: Here's What You Need To Know
